Tempest Therapeutics (TPST) Other Non-Current Liabilities (2011 - 2020)

Tempest Therapeutics has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $7000.0 for Q1 2020.

• In Q1 2020, Other Non-Current Liabilities fell 96.35% year-over-year to $7000.0; the TTM figure through Mar 2020 stood at $7000.0 (down 96.35% YoY), while the FY2019 annual figure was $16000.0, down 97.87% from the prior year.
• Other Non-Current Liabilities came in at $7000.0 for Q1 2020 at Tempest Therapeutics, down from $16000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.1 million in Q4 2016 to a low of $7000.0 in Q1 2020.
• Average Other Non-Current Liabilities over 5 years is $552642.9, with a median of $620000.0 recorded in 2018.
• Year-over-year, Other Non-Current Liabilities soared 114.62% in 2016 and tumbled 97.87% in 2019.
• Over 5 years, Other Non-Current Liabilities stood at $1.1 million in 2016, then plunged by 32.71% to $751000.0 in 2017, then grew by 0.13% to $752000.0 in 2018, then plunged by 97.87% to $16000.0 in 2019, then sank by 56.25% to $7000.0 in 2020.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $7000.0 in Q1 2020, $16000.0 in Q4 2019, and $229000.0 in Q3 2019.